Literature DB >> 26621638

Using Clinical Trial End Points to Risk Stratify Patients With Pulmonary Arterial Hypertension.

Aaron B Waxman1, Harrison W Farber2.   

Abstract

Entities:  

Keywords:  clinical trial; hypertension, pulmonary; patient outcome assessment; performance measure

Mesh：

Year:  2015        PMID： 26621638     DOI： 10.1161/CIRCULATIONAHA.114.012328

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

Review 1.  A Contemporary Approach to Pulmonary Arterial Hypertension.

Authors:  Udhay Krishnan; Evelyn M Horn
Journal:  Curr Atheroscler Rep       Date:  2016-09       Impact factor: 5.113

2.  Systemic-to-pulmonary artery pressure ratio as a predictor of patient outcome following liver transplantation.

Authors:  Annette Rebel; Dung Nguyen; Brooke Bauer; Paul A Sloan; Amy DiLorenzo; Zaki-Udin Hassan
Journal:  World J Hepatol       Date:  2016-11-18

3.  A modified risk score in one-year survival rate assessment of group 1 pulmonary arterial hypertension.

Authors:  Wei Xiong; Yunfeng Zhao; Mei Xu; Bigyan Pudasaini; Xuejun Guo; Jinming Liu
Journal:  BMC Pulm Med       Date:  2018-10-16       Impact factor: 3.317

Review 4.  The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension.

Authors:  Samantha L Wronski; Margaret Mordin; Kim Kelley; Rebekah H Anguiano; Peter Classi; Eric Shen; Scott Manaker
Journal:  Lung       Date:  2019-11-13       Impact factor: 2.584

Review 5.  Advances in the management of pulmonary arterial hypertension.

Authors:  Himanshu Deshwal; Tatiana Weinstein; Roxana Sulica
Journal:  J Investig Med       Date:  2021-10       Impact factor: 2.895
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.